Bariatric Surgery Devices Market By Procedure Type (Minimally Invasive Surgical Procedures, Non-Invasive Surgical Procedures); By Procedure (Adjustable Gastric Binding (AGB), Vertical Sleeve Gastrectomy (VSG), Roux-en-Y Gastric Bypass (RYGB), Biliopancreatic Diversion with a Duodenal Switch (BPD-DS), Revision Bariatric Surgery, Mini-gastric Bypass, Others); By Procedure Type (Assisting Devices, Implantable Devices); By Application (Weight Loss, Hereditary Disease, Other Disorders); By End User (Hospitals, Specialty Centers, Ambulatory Surgical Centers, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Market Analysis, Trends, Opportunity and Forecast, 2023-2032
Bariatric Surgery Devices Market Overview
The global bariatric surgery devices market size was estimated to be worth USD 1.8 billion in 2022 and is poised to reach USD 3.5 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Bariatric surgeries also referred to as weight loss surgeries generally include a variety of procedures performed on the gastrointestinal tract of people who are obese. It is typically carried out for the treatment of the co-morbid condition that is associated with morbid obesity.
Bariatric surgery predominantly aims to reduce the weight of an individual with the help of a surgery that reduces the size of stomach by removing a portion of tissues or fats of the stomach or by altering gut hormone levels that are responsible for hunger and satiety, resulting in a new hormonal weight set point leading to reduction in appetite. Bariatric surgery devices are clinical equipments or devices used to perform such highly sophisticated bariatric surgeries for weight loss. They limit the food holding capacity of stomach, thereby causing nutrients malabsorption. There are different devices used in different procedures of bariatric surgeries as per the functionality and requirement of the devices.
Bariatric Surgery Devices Market Drivers
The growth of this market is attributed towards major relying factors including; the burgeoning incidence of obesity in adults worldwide as a result of changing lifestyle habits and excessive intake of calories, the increasing number of bariatric and metabolic surgeries performed globally, the rapidly increasing co-morbidities such as diabetes, the rising number of regulatory approvals for bariatric surgery devices, the rapid emergence of minimally invasive (MI) bariatric procedures with reduced postoperative stress, the rising awareness about the adverse effects of obesity and the available treatment options among people and the rising expenditure on weight loss procedures etc.
Additionally, the advent of newer and advanced medical technologies by the market players in the bariatric surgery market is leading to the introduction and launch of innovative surgical devices with enhanced features and outcomes. Some popular developments include the development of device with improved cosmetic results and minimal pain, the introduction of a device by Medtronic for sleeve gastrectomy that can be used as standalone device, whereas, the traditional method of performing sleeve gastrectomy involves the use of three devices coupled with the improvements in the surgical procedures such as Hand-Assisted Laparoscopic Surgery (HALS), Primary Obesity Surgery Endoluminal (POSE) and Laparoscopic Greater Curvature Plication (LGCP) etc. Alongside, the bolstering trend of rapid integration of surgical robots with bariatric equipment and minimally invasive surgeries coupled with the growing demand for various visualization instruments augment the growth of the bariatric surgery devices market considerably.
Moreover, governments across different regions are rolling out favorable initiatives for research programs focused at obesity treatment and insurance coverage for the treatment of obesity. For instance, the recent introduction of the Treat and Reduce Obesity Act, 2017 is set to increase the range of obesity treatments that Medicare is currently said to cover. As per the data published by the Obesity Society, only around 26% of the obese population in the U.S. is at present covered under the Medicare, Medicaid and other essential health benefit plans under the Affordable Care Act (ACA). This vigorously expands the overall demand and adoption of bariatric surgeries across the globe and hence leads to the comprehensive growth of the bariatric surgery devices market.
Furthermore, other factors such as the high adoption of sedentary consumer lifestyle along with unhealthy food habits among people, the lack of physical exercise in adolescent and adult population, the increasing availability of surgeons specialized in bariatric surgical techniques and the emerging trend of medical tourism across regions further contribute exponentially in the growth of the bariatric surgery devices market.
However, factors such as the increasing number of product recalls of various bariatric devices, the post-operative complications of bariatric surgeries, the high costs associated with bariatric surgeries and the presence of stringent regulatory scenario in developed countries hamper the growth of this market.
Bariatric Surgery Devices Market Segmentation
By Device Type
- Assisting Devices
- Stapling Devices
- Energy Based Vessel Sealing Devices
- Suturing Devices
- Clip Appliers
- Implantable Devices
- Gastric Bands
- Electrical Stimulators
- Gastric Balloons
- Transpyloric Shuttle
By Procedure Type
- Minimally Invasive Surgical Procedures
- Non-Invasive Surgical Procedures
- Adjustable Gastric Binding (AGB)
- Vertical Sleeve Gastrectomy (VSG)
- Roux-en-Y Gastric Bypass (RYGB)
- Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)
- Revision Bariatric Surgery
- Mini-gastric Bypass
- Weight Loss
- Hereditary Disease
- Other Disorders
By End User
- Specialty Centers
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Bariatric Surgery Devices Market Regional Insight
The North American region is the most prominent regional market for bariatric surgery devices followed by Europe which is further expected to continue to dominate the market in the forthcoming years as well. The growth in the region could be accounted to factors such as the massively surging rates of obesity in the region, the increasing number of bariatric surgeries in the region, the presence of well-established key players in the region, the rising government efforts to control obesity in the region, the proliferating risks of diabetes and blood pressure disorders in the region, the growing development of effective and minimally invasive surgical procedures in the region and the spurring adoption of unhealthy lifestyle among people leading to rising healthcare expenditures and adoption of bariatric procedures etc. The major contributors in the region include the U.S and Canada.
The Asia Pacific region is the fastest growing regional market for bariatric surgery devices and the same is expected to continue witnessing growth at a robust growth rate in the upcoming years as well. The growth in the region could be attributed to various factors such as the proliferating patient pool suffering from obesity and other lifestyle diseases in the region, the colossal developments in healthcare technologies coupled with advancements in healthcare facilities in the region, the spurring medical tourism due to availability of surgeries at affordable costs in the region and the presence of major industry players in the region etc. Furthermore, the massive surge in geriatric population, the rising disposable incomes of people and the rising healthcare expenditure in the region also boosts the region’s bariatric surgery devices market growth significantly. The major contributors in the region include India, China and Japan.
Bariatric Surgery Devices Market Key Players
- Mediflex Surgical Procedure
- Medtronic plc.
- Intuitive Surgical Inc.
- Apollo Endosurgery
- Olympus Corporation of the Americas
- Aspire Bariatrics
- Reach Surgical Inc.
- Cousin Biotech
- Endogastric Solutions Inc.
- EntroMedics Inc.
- ReShape Medical Inc.
- Integra Life Sciences
- B. Braun
- W. L. Gore & Associates
- Johnson & Johnson Services Inc.
- Allergan Inc.
- Cousin Biotech
- Pare Surgical Inc.
- Covidien Plc
- GI Dynamics Inc.
- TransEnterix Inc.
- USGI Medical Inc.
- Semiled Ltd.
- Spatz Fgia Inc.
- Standard Bariatrics
- Other Players
- In February 2020, Medtronic acquired Digital Surgery, a major player in surgical Artificial Intelligence (AI), data & analytics. This acquisition strengthened Medtronic’s robotic-assisted surgery platform and broadened its product portfolio substantially.
- In March 2021, Origami Surgical announced that the FDA granted 510(k) clearance for three new types of sutures for its StitchKit robotic surgery platform. The company describes StitchKit as a patented suture delivery and retrieval system designed so that sutures are efficiently inserted and needles are safely removed from the surgical field. Origami Surgical’s newly cleared absorbable and non-absorbable sutures were designed based on input from surgeons who perform robotic hernia, prostate and bariatric procedures.